Abstract
Down syndrome (DS) originates, in most of the cases (95 %), from a full trisomy of chromosome 21. The remaining cases are due to either mosaicism for chromosome 21 or the inheritance of a structural rearrangement leading to partial trisomy of the majority of its content. Full trisomy 21 and mosaicism are not inherited, but originate from errors in cell divisions during the development of the egg, sperm or embryo. In addition, full trisomy for chromosome 21 should be further divided into cases of maternal origin, the majority, and cases of paternal origin, less than 10 %. Among cases of maternal origin, a further stratification should be performed into errors that have occurred or originated during the first meiotic division in the maternal grandmother’s body and errors that occurred later in life during the second maternal meiotic division. This complex scenario suggests that our understanding of the risk factors for trisomy 21 should take into account the above stratification as it reflects different individuals and generations in which the first error has occurred. Unfortunately, most of the available literature is focused on maternal risk factors, and the only certain risk factors for the birth of a child with DS are advanced maternal age at conception and recombination errors, even though the molecular mechanisms leading to chromosome 21 nondisjunction are still a matter of debate. This article critically reviews the hypotheses and the risk factors which have been suggested to contribute to the birth of a child with DS, including folate metabolism, dietary, lifestyle, environmental, occupational, genetic and epigenetic factors, with focus on maternal and paternal risk factors, and taking into account the possible contribution of the maternal grandmother and that of the developing trisomic embryo, in a complex scenario depicting the birth of a child with DS as the result of complex gene–environment interactions and selection processes involving different generations.
Similar content being viewed by others
References
Abdel Hady S, Afifi HH, Abdel Ghany EA, Taher MB, Eid MM (2015) Micronucleus assay as a biomarker for chromosome malsegregation in young mothers with Down syndrome children. Genet Couns 26:13–19
Albizua I, Rambo-Martin BL, Allen EG, He W, Amin AS, Sherman SL (2015) Association between telomere length and chromosome 21 nondisjunction in the oocyte. Hum Genet 134:1263–1270
Alverson CJ, Strickland MJ, Gilboa SM, Correa A (2011) Maternal smoking and congenital heart defects in the Baltimore-Washington Infant Study. Pediatrics 127:e647–e653
Antonarakis SE (1998) Down syndrome. In: Jameson JL (ed) Principle of molecular medicine. Humana Press Inc, Totowa, pp 1069–1078
Asim A, Kumar A, Muthuswamy S, Jain S, Agarwal S (2015) Down syndrome: an insight of the disease. J Biomed Sci 22:41
Bacalini MG, Gentilini D, Boattini A, Giampieri E, Pirazzini C, Giuliani C, Fontanesi E, Scurti M, Remondini D, Capri M, Cocchi G, Ghezzo A, Del Rio A, Luiselli D, Vitale G, Mari D, Castellani G, Fraga M, Di Blasio AM, Salvioli S, Franceschi C, Garagnani P (2015) Identification of a DNA methylation signature in blood cells from persons with Down syndrome. Aging (Albany NY) 7:82–96
Bean LJ, Allen EG, Tinker SW, Hollis ND, Locke AE, Druschel C, Hobbs CA, O’Leary L, Romitti PA, Royle MH, Torfs CP, Dooley KJ, Freeman SB, Sherman SL (2011) Lack of maternal folic acid supplementation is associated with heart defects in Down syndrome: a report from the National Down Syndrome Project. Birth Defects Res A Clin Mol Teratol 91:885–893
Beetstra S, Thomas P, Salisbury C, Turner J, Fenech M (2005) Folic acid deficiency increases chromosomal instability, chromosome 21 aneuploidy and sensitivity to radiation-induced micronuclei. Mutat Res 578:317–326
Bergström S, Carr H, Petersson G, Stephansson O, Bonamy AK, Dahlström A, Halvorsen CP, Johansson S (2016) Trends in congenital heart defects in infants with Down syndrome. Pediatrics. doi:10.1542/peds.2016-0123
Biselli JM, Goloni-Bertollo EM, Zampieri BL, Haddad R, Eberlin MN, Pavarino-Bertelli EC (2008) Genetic polymorphisms involved in folate metabolism and elevated plasma concentrations of homocysteine: maternal risk factors for Down syndrome in Brazil. Genet Mol Res 7:33–42
Božović IB, Stanković A, Živković M, Vraneković J, Kapović M, Brajenović-Milić B (2015) Altered LINE-1 methylation in mothers of children with Down syndrome. PLoS One 10:e0127423
Brandalize AP, Bandinelli E, dos Santos PA, Roisenberg I, Schüler-Faccini L (2009) Evaluation of C677T and A1298C polymorphisms of the MTHFR gene as maternal risk factors for Down syndrome and congenital heart defects. Am J Med Genet A 149A:2080–2087
Brandalize AP, Bandinelli E, Dos Santos PA, Schüler-Faccini L (2010) Maternal gene polymorphisms involved in folate metabolism as risk factors for Down syndrome offspring in Southern Brazil. Dis Markers 29:95–101
Clarke CM, Edwards JH, Smallpeice V (1961) 21-Trisomy/normal mosaicism in an intelligent child with some mongoloid characters. Lancet 1:1028–1030
Coppedè F (2009) The complex relationship between folate/homocysteine metabolism and risk of Down syndrome. Mutat Res 682:54–70
Coppedè F (2015) The genetics of folate metabolism and maternal risk of birth of a child with Down syndrome and associated congenital heart defects. Front Genet 6:223
Coppedè F, Colognato R, Bonelli A, Astrea G, Bargagna S, Siciliano G, Migliore L (2007) Polymorphisms in folate and homocysteine metabolizing genes and chromosome damage in mothers of Down syndrome children. Am J Med Genet A 143A:2006–2015
Coppedè F, Migheli F, Bargagna S, Siciliano G, Antonucci I, Stuppia L, Palka G, Migliore L (2009) Association of maternal polymorphisms in folate metabolizing genes with chromosome damage and risk of Down syndrome offspring. Neurosci Lett 449:15–19
Coppedè F, Lorenzoni V, Migliore L (2013) The reduced folate carrier (RFC-1) 80A>G polymorphism and maternal risk of having a child with Down syndrome: a meta-analysis. Nutrients 5:2551–2563
Coppedè F, Bosco P, Lorenzoni V, Denaro M, Anello G, Antonucci I, Barone C, Stuppia L, Romano C, Migliore L (2014) The MTRR 66A>G polymorphism and maternal risk of birth of a child with Down syndrome in Caucasian women: a case–control study and a meta-analysis. Mol Biol Rep 41:5571–5583
Coppedè F, Denaro M, Tannorella P, Migliore L (2016) Increased MTHFR promoter methylation in mothers of Down syndrome individuals. Mutat Res 787:1–6
Dekker AD, De Deyn PP, Rots MG (2014) Epigenetics: the neglected key to minimize learning and memory deficits in Down syndrome. Neurosci Biobehav Rev 45:72–84
Dekker AD, Strydom A, Coppus AM, Nizetic D, Vermeiren Y, Naudé PJ, Van Dam D, Potier MC, Fortea J, De Deyn PP (2015) Behavioural and psychological symptoms of dementia in Down syndrome: early indicators of clinical Alzheimer’s disease? Cortex 73:36–61
Dobson R (2003) Painting is earliest example of portrayal of Down’s syndrome. BMJ 326:126
Donate A, Estop AM, Giraldo J, Templado C (2016) Paternal age and numerical chromosome abnormalities in human spermatozoa. Cytogenet Genome Res. doi:10.1159/000446724
Down JLH (1866) Observations of an ethnic classification of idiots. Lond Hosp Rep 3:259–262
Erickson JD, Bjerkedal TO (1981) Down syndrome associated with father’s age in Norway. J Med Genet 18:22–28
Fitzgerald PH, Lycette RR (1961) Mosaicism inmaninvolving the autosome associated with mongolism. Heredity 16:509–512
Flores-Ramírez F, Palacios-Guerrero C, García-Delgado C, Morales-Jiménez AB, Arias-Villegas CM, Cervantes A, Morán-Barroso VF (2015) Cytogenetic profile in 1,921 cases of trisomy 21 syndrome. Arch Med Res 46:484–489
Ghosh S, Hong CS, Feingold E, Ghosh P, Ghosh P, Bhaumik P, Dey SK (2011) Epidemiology of Down syndrome: new insight into the multidimensional interactions among genetic and environmental risk factors in the oocyte. Am J Epidemiol 174:1009–1016
Ghosh S, Ghosh P, Dey SK (2014) Altered incidence of meiotic errors and Down syndrome birth under extreme low socioeconomic exposure in the Sundarban area of India. J Community Genet 5:119–124
Grieco J, Pulsifer M, Seligsohn K, Skotko B, Schwartz A (2015) Down syndrome: cognitive and behavioral functioning across the lifespan. Am J Med Genet C Semin Med Genet 169:135–149
Hassold T, Sherman S (2000) Down syndrome: Genetic recombination and the origin of the extra chromosome 21. Clin Genet 57:95–100
Hildebrand E, Källén B, Josefsson A, Gottvall T, Blomberg M (2014) Maternal obesity and risk of Down syndrome in the offspring. Prenat Diagn 34:310–315
Hollis ND, Allen EG, Oliver TR, Tinker SW, Druschel C, Hobbs CA, O’Leary LA, Romitti PA, Royle MH, Torfs CP, Freeman SB, Sherman SL, Bean LJ (2013) Preconception folic acid supplementation and risk for chromosome 21 nondisjunction: a report from the National Down Syndrome Project. Am J Med Genet A 161A:438–444
Huang T, Meschino WS, Okun N, Dennis A, Hoffman B, Lepage N, Rashid S, Aul R, Farrell SA (2013) The impact of maternal weight discrepancies on prenatal screening results for Down syndrome. Prenat Diagn 33:471–476
Hultén MA, Patel SD, Tankimanova M, Westgren M, Papadogiannakis N, Jonsson AM, Iwarsson E (2008) On the origin of trisomy 21 down syndrome. Mol Cytogenet 1:21
Hultén MA, Patel SD, Westgren M, Papadogiannakis N, Jonsson AM, Jonasson J, Iwarsson E (2010) On the paternal origin of trisomy 21 Down syndrome. Mol Cytogenet 3:4
Hultén MA, Öijerstedt L, Iwarsson E, Jonasson J (2014) Maternal germinal trisomy 21 in Down syndrome. J Clin Med 3:167–175
Hunter JE, Allen EG, Shin M, Bean LJ, Correa A, Druschel C, Hobbs CA, O’Leary LA, Romitti PA, Royle MH, Torfs CP, Freeman SB, Sherman SL (2013) The association of low socioeconomic status and the risk of having a child with Down syndrome: a report from the National Down Syndrome Project. Genet Med 15:698–705
James SJ, Pogribna M, Pogribny IP, Melnyk S, Hine RJ, Gibson JB, Yi P, Tafoya DL, Swenson DH, Wilson VL, Gaylor DW (1999) Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 70:495–501
Jurewicz J, Radwan M, Sobala W, Radwan P, Jakubowski L, Hawuła W, Ulańska A, Hanke W (2014) Lifestyle factors and sperm aneuploidy. Reprod Biol 14:190–199
Jurewicz J, Radwan M, Sobala W, Polańska K, Radwan P, Jakubowski L, Ulańska A, Hanke W (2015) The relationship between exposure to air pollution and sperm disomy. Environ Mol Mutagen 56:50–59
Jurewicz J, Radwan M, Sobala W, Gromadzińska J, Jabłońska E, Radwan P, Jakubowski L, Wąsowicz W, Hanke W (2016) Dietary patterns and the frequency of disomy in human sperm. Urology 93:86–91
Karmiloff-Smith A, Al-Janabi T, D’Souza H, Groet J, Massand E, Mok K, Startin C, Fisher E, Hardy J, Nizetic D, Tybulewicz V, Strydom A (2016) The importance of understanding individual differences in Down syndrome. F1000 Res 23:5. doi:10.12688/f1000research.7506.1
Kuliev A, Zlatopolsky Z, Kirillova I, Spivakova J, Cieslak Janzen J (2011) Meiosis errors in over 20,000 oocytes studied in the practice of preimplantation aneuploidy testing. Reprod Biomed Online 22:2–8
Lamb NE, Feingold E, Savage A, Avramopoulos D, Freeman S, Gu Y, Hallberg A, Hersey J, Karadima G, Pettay D, Saker D, Shen J, Taft L, Mikkelsen M, Petersen MB, Hassold T, Sherman SL (1997) Characterization of susceptible chiasma configurations that increase the risk for maternal nondisjunction of chromosome 21. Hum Mol Genet 6:1391–1399
Lejeune J, Gautier M, Turpin R (1959) Etude des chromosomes somatiqaues de neuf enfants mongoliens. Compte Rendu d’Acad Sci 248:1721–1722
Levitas AS, Reid CS (2003) An angel with Down syndrome in a sixteenth century Flemish Nativity painting. Am J Med Genet A 116A:399–405
Loane M, Morris JK, Addor MC, Arriola L, Budd J, Doray B, Garne E, Gatt M, Haeusler M, Khoshnood B, Klungsoyr Melve K, Latos-Bielenska A, McDonnell B, Mullaney C, O’Mahony M, Queisser-Wahrendorf A, Rankin J, Rissmann A, Rounding C, Salvador J, Tucker D, Wellesley D, Yevtushok L, Dolk H (2013) Twenty-year trends in the prevalence of down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening. Eur J Hum Genet 21:27–33
Locke AE, Dooley KJ, Tinker SW, Cheong SY, Feingold E, Allen EG, Freeman SB, Torfs CP, Cua CL, Epstein MP, Wu MC, Lin X, Capone G, Sherman SL, Bean LJ (2010) Variation in folate pathway genes contributes to risk of congenital heart defects among individuals with Down syndrome. Genet Epidemiol 34:613–623
Lu J, Mccarter M, Lian G, Esposito G, Capoccia E, Delli-Bovi LC, Hecht J, Sheen V (2016) Global hypermethylation in fetal cortex of Down syndrome due to DNMT3L overexpression. Hum Mol Genet 25:1714–1727
Martin JA, Hamilton BE, Ventura SJ, Osterman MJ, Wilson EC, Mathews TJ (2012) Births: final data for 2010. Natl Vital Stat Rep 61:1–71
Martinez-Frias ML (2005) The real earliest historical evidence of Down syndrome. Am J Med Genet A 132A:231
Martínez-Frías ML, Pérez B, Desviat LR, Castro M, Leal F, Rodríguez L, Mansilla E, Martínez-Fernández ML, Bermejo E, Rodríguez-Pinilla E, Prieto D, Ugarte M, ECEMC Working Group (2006) Maternal polymorphisms 677C-T and 1298A-C of MTHFR, and 66A-G MTRR genes: is there any relationship between polymorphisms of the folate pathway, maternal homocysteine levels, and the risk for having a child with Down syndrome? Am J Med Genet A 140:987–997
Mateos MK, Barbaric D, Byatt SA, Sutton R, Marshall GM (2015) Down syndrome and leukemia: insights into leukemogenesis and translational targets. Transl Pediatr 4:76–92
Migliore L, Boni G, Bernardini R, Trippi F, Colognato R, Fontana I, Coppedè F, Sbrana I (2006) Susceptibility to chromosome malsegregation in lymphocytes of women who had a Down syndrome child in young age. Neurobiol Aging 27:710–716
Migliore L, Migheli F, Coppedè F (2009) Susceptibility to aneuploidy in young mothers of Down syndrome children. ScientificWorldJournal 9:1052–1060
Migliore L, Coppedè F, Fenech M, Thomas P (2011) Association of micronucleus frequency with neurodegenerative diseases. Mutagenesis 26:85–92
Morris JK (2012) Trisomy 21 mosaicism and maternal age. Am J Med Genet Part A 158A:2482–2484
Morris JK, Mutton DE, Alberman E (2002) Revised estimates of the maternal age specific live birth prevalence of Down’s syndrome. J Med Screen 9:2–6
Morris JK, Wald NJ, Mutton DE, Alberman E (2003) Comparison of models of maternal age-specific risk for Down syndrome live births. Prenat Diagn 23:252–258
Norwitz ER, Levy B (2013) Noninvasive prenatal testing: the future is now. Rev Obstet Gynecol 6:48–62
Obermann-Borst SA, van Driel LM, Helbing WA, de Jonge R, Wildhagen MF, Steegers EA, Steegers-Theunissen RP (2011) Congenital heart defects and biomarkers of methylation in children: a case-control study. Eur J Clin Invest 41:143–150
Oliver TR, Feingold E, Yu K, Cheung V, Tinker S, Yadav-Shah M, Masse N, Sherman SL (2008) New insights into human nondisjunction of chromosome 21 in oocytes. PLoS Genet 4:e1000033
Oliver TR, Bhise A, Feingold E, Tinker S, Masse N, Sherman SL (2009) Investigation of factors associated with paternal nondisjunction of chromosome 21. Am J Med Genet A 149A:1685–1690
Oliver TR, Tinker SW, Allen EG, Hollis N, Locke AE, Bean LJ, Chowdhury R, Begum F, Marazita M, Cheung V, Feingold E, Sherman SL (2012) Altered patterns of multiple recombinant events are associated with nondisjunction of chromosome 21. Hum Genet 131:1039–1046
Oliver TR, Middlebrooks CD, Tinker SW, Allen EG, Bean LJ, Begum F, Feingold E, Chowdhury R, Cheung V, Sherman SL (2014) An examination of the relationship between hotspots and recombination associated with chromosome 21 nondisjunction. PLoS One 9:e99560
Oster-Granite ML, Parisi MA, Abbeduto L, Berlin DS, Bodine C, Bynum D, Capone G, Collier E, Hall D, Kaeser L, Kaufmann P, Krischer J, Livingston M, McCabe LL, Pace J, Pfenninger K, Rasmussen SA, Reeves RH, Rubinstein Y, Sherman S, Terry SF, Whitten MS, Williams S, McCabe ER, Maddox YT (2011) Down syndrome: national conference on patient registries, research databases, and biobanks. Mol Genet Metab 104:13–22
Papavassiliou P, Charalsawadi C, Rafferty K, Jackson-Cook C (2015) Mosaicism for trisomy 21: a review. Am J Med Genet A 167A:26–39
Patterson D (2009) Molecular genetic analysis of Down syndrome. Hum Genet 126:195–214
Radwan M, Jurewicz J, Radwan P, Ulańska A, Jakubowski L, Hanke W (2015a) Occupational risk factors and frequency of sex chromosome disomy. Hum Fertil (Camb) 18:200–207
Radwan M, Jurewicz J, Wielgomas B, Piskunowicz M, Sobala W, Radwan P, Jakubowski L, Hawuła W, Hanke W (2015b) The association between environmental exposure to pyrethroids and sperm aneuploidy. Chemosphere 128:42–48
Ren H, Ferguson K, Kirkpatrick G, Vinning T, Chow V, Ma S (2016) Altered crossover distribution and frequency in spermatocytes of infertile men with Azoospermia. PLoS One 11:e0156817
Roizen NJ, Patterson D (2003) Down’s syndrome. Lancet 361:1281–1289
Rowsey R, Kashevarova A, Murdoch B, Dickenson C, Woodruff T, Cheng E, Hunt P, Hassold T (2013) Germline mosaicism does not explain the maternal age effect on trisomy. Am J Med Genet A 161A:2495–2503
Sailani MR, Santoni FA, Letourneau A, Borel C, Makrythanasis P, Hibaoui Y, Popadin K, Bonilla X, Guipponi M, Gehrig C, Vannier A, Carre-Pigeon F, Feki A, Nizetic D, Antonarakis SE (2015) DNA-methylation patterns in trisomy 21 using cells from monozygotic twins. PLoS One 10:e0135555
Schupf N, Kapell D, Nightingale B, Lee JH, Mohlenhoff J, Bewley S, Ottman R, Mayeux R (2001) Specificity of the fivefold increase in AD in mothers of adults with Down syndrome. Neurology 57:979–984
Séguin E (1846) Traitement moral, hygiène et éducation des idiots et des autres enfants arrières. JB Baillière, Paris
Serra-Juhé C, Cuscó I, Homs A, Flores R, Torán N, Pérez-Jurado LA (2015) DNA methylation abnormalities in congenital heart disease. Epigenetics 10:167–177
Sperling K, Neitzel H, Scherb H (2012) Evidence for an increase in trisomy 21 (Down syndrome) in Europe after the Chernobyl reactor accident. Genet Epidemiol 36:48–55
Stahl A, Tourame P (2013) Trisomy 21 in visual art. Arch Pediatr 20:1342–1351
Steiner B, Masood R, Rufibach K, Niedrist D, Kundert O, Riegel M, Schinzel A (2015) An unexpected finding: younger fathers have a higher risk for offspring with chromosomal aneuploidies. Eur J Hum Genet 23:466–472
Stene J, Stene E, Stengel-Rutkowski S, Murken JD (1981) Paternal age and Down’s syndrome: data from prenatal diagnoses (DFG). Hum Genet 59:119–124
Sukla KK, Jaiswal SK, Rai AK, Mishra OP, Gupta V, Kumar A, Raman R (2015) Role of folate-homocysteine pathway gene polymorphisms and nutritional cofactors in Down syndrome: A triad study. Hum Reprod 30:1982–1993
Tannorella P, Stoccoro A, Tognoni G, Petrozzi L, Salluzzo MG, Ragalmuto A, Siciliano G, Haslberger A, Bosco P, Bonuccelli U, Migliore L, Coppedè F (2015) Methylation analysis of multiple genes in blood DNA of Alzheimer’s disease and healthy individuals. Neurosci Lett 600:143–147
Templado C, Vidal F, Estop A (2011) Aneuploidy in human spermatozoa. Cytogenet Genome Res 133:91–99
Victorino DB, Godoy MF, Goloni-Bertollo EM, Pavarino EC (2014) Meta-analysis of Methylenetetrahydrofolate reductase maternal gene in Down syndrome: increased susceptibility in women carriers of the MTHFR 677T allele. Mol Biol Rep 41:5491–5504
Vineis P, Chuang SC, Vaissière T, Cuenin C, Ricceri F, Collaborators Genair-EPIC, Johansson M, Ueland P, Brennan P, Herceg Z (2011) DNA methylation changes associated with cancer risk factors and blood levels of vitamin metabolites in a prospective study. Epigenetics 6:195–201
Wang X, Thomas P, Xue J, Fenech M (2004) Folate deficiency induces aneuploidy in human lymphocytes in vitro-evidence using cytokinesis-blocked cells and probes specific for chromosomes 17 and 21. Mutat Res 551:167–180
Wang SS, Feng L, Qiao FY, Lv JJ (2013) Functional variant in methionine synthase reductase decreases the risk of Down syndrome in China. J Obstet Gynaecol Res 39:511–515
Warren AC, Chakravarti A, Wong C, Slaugenhaupt SA, Halloran SL, Watkins PC, Metaxotou C, Antonarakis SE (1987) Evidence for reduced recombination on the nondisjoined chromosomes 21 in Down syndrome. Science 237:652–654
Weijerman ME, de Winter JP (2010) Clinical practice. The care of children with Down syndrome. Eur J Pediatr 169:1445–1452
Wiseman FK, Al-Janabi T, Hardy J, Karmiloff-Smith A, Nizetic D, Tybulewicz VL, Fisher EM, Strydom A (2015) A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome. Nat Rev Neurosci 16:564–574
Yang Q, Sherman SL, Hassold TJ, Allran K, Taft L, Pettay D, Khoury MJ, Erickson JD, Freeman SB (1999) Risk factors for trisomy 21: maternal cigarette smoking and oral contraceptive use in a population-based case-control study. Genet Med 1:80–88
Yang M, Gong T, Lin X, Qi L, Guo Y, Cao Z, Shen M, Du Y (2013) Maternal gene polymorphisms involved in folate metabolism and the risk of having a Down syndrome offspring: a meta-analysis. Mutagenesis 28:661–671
Young SS, Eskenazi B, Marchetti FM, Block G, Wyrobek AJ (2008) The association of folate, zinc and antioxidant intake with sperm aneuploidy in healthy non-smoking men. Hum Reprod 23:1014–1022
Zhao J, Tharapel AT, Shulman LP, Simpson JL, Elias S (1994) Molecular analysis to assign parental origin and distinguish de novo i(21q) from t(21q21q) in two Down syndrome fetuses. J Soc Gynecol Investig 1:128–130
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Coppedè, F. Risk factors for Down syndrome. Arch Toxicol 90, 2917–2929 (2016). https://doi.org/10.1007/s00204-016-1843-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-016-1843-3